Results of integrated treatment of herpetic stomatitis with the inclusion of lipid concentrate of ERYX biomass
https://doi.org/10.36377/1683-2981-2020-18-3-26-31
Abstract
Aim. The study of the effectiveness of the use of the biologically active additive Reptin-plant in the complex treatment of patients with herpetic stomatitis.
Materials and methods. We examined 189 patients with a diagnosis of herpetic stomatitis, which were divided into 2 groups depending on the receipt of complex antiviral therapy with the inclusion of ERYX biomass lipid concentrate in the treatment regimen and without it. The following were assessed: clinical status, index assessment of the state of the oral cavity, state of local immunity, frequency of relapses and duration of the latency period.
Results. 57 (30.2%) patients were identified with a mild form of herpetic stomatitis (HS), the average severity of HS was determined in 93 (49.2%) and a severe course of the disease was diagnosed in 39 (20.6%) patients. Analysis of the index assessment of the state of the oral cavity (OHIS, PMA), molecular genetic parameters, immunological studies (lysozyme titer, phagocytosis, concentration of sIg A in saliva) showed a statistically significant difference when included in the complex treatment of Reptin-plant, demonstrating the benefits of using it.
Conclusions. The use of ERYX biomass lipid concentrate in the complex treatment of herpetic stomatitis effectively affects the dynamics of the course of the disease, improves the quality of life of patients.
About the Authors
K. P. Kamilov
Tashkent State Dentistry Medical Institute
Uzbekistan
Head of Hospital Therapeutic Dentistry Department, Professor, Doctor of Medical Sciences
Uzbekistan
Head of Hospital Therapeutic Dentistry Department, Professor, Doctor of Medical Sciences
G. I. Lukina
Moscow State Medical University of Dentistry named after A.I. Evdokimov
Russian Federation
Professor of Department of Therapeutic Dentistry, professor, Doctor of Medical Sciences
Russian Federation
Professor of Department of Therapeutic Dentistry, professor, Doctor of Medical Sciences
F. A. Shokirova
Tashkent State Dentistry Medical Institute
Uzbekistan
Assistant of Department of Hospital Therapeutic Dentistry
Uzbekistan
Assistant of Department of Hospital Therapeutic Dentistry
G. I. Sharipova
Dental practice
Uzbekistan
Uzbekistan
Dentist
Bukhara
References
1.
2. Bazarny V.V., Vanevskaya E.A., Popova I.G., Kosareva O.V., Mandra Yu.V. Evaluation of secretory immunity in case of herpetic lesions of the oral cavity. Clinical laboratory diagnostics. 2013; 7: 62-63.
3. Vanevskaya E.A., Mandra Yu.V. Comprehensive analysis of the somatic, social and dental status of patients with manifestations of herpes infection in the oral cavity. Dentistry problems. 2012; 3: 26-28.
4. Dolgikh T.I., Minakova E.Yu., Serbaev D.A. Herpesvirus infections: a diagnostic strategy. Polyclinic. 2014; 4 (1): 4-7.
5. Zolotukhina E.L. Study of immunological processes and indices of local immunity of the oral mucosa in recurrent herpetic stomatitis. Molody Vcheny. 2015: 26 (17): 612-614.
6. Kamilov H.P., Kamalova M.K., Increasing the effectiveness of complex treatment of acute herpetic stomatitis in children. Norwegian journal of international science. 2017; 10: 35-37.
7. Kamilov Kh.P., Kamalova M.K. Modern approaches in the treatment of chronic recurrent herpetic stomatitis in children. Achievements of Science and Education, International Scientific Journal Moscow. 2018; 25 (3): 46-48.
8. Lutskaya I.K. Herpetic stomatitis: clinic, diagnosis, treatment. Consilium medicum, 2016; 4: 48-50.
9. Murina E.A., Goleva O.V., Osipova Z.A. Etiological monitoring of patients with infections caused by herpes viruses type 1, 2 (virological observations). Journal of Infectology. Application. 2015; 7 (4): 92-93.
10. Tirskaya O.I., Molokov V.D. Herpes infection in the oral cavity: a modern view of the problem. Bulletin of the North-Eastern Federal University. M.K. Amosova, 2015: 135- 139.
11. Yanovskiy L.M., Kovtonyuk P.A. Acute herpetic stomatitis in children: an algorithm of therapeutic measures. Siberian Medical Journal. 2015; 1: 126-128.
12. Chentoufi A.A., Dervillez X., Dasgupta G., Nguyen C. The herpes simplex virus type 1 latency-associated transcript inhibits phenotypic and functional maturation of dendritic cells. Viral Immunol. 2012; 25 (3): 204-215.
13. Jacob Amir. Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis. Adis International Limited. All rights reserved. Paediatr Drugs. 2001.8 (3): 594-597.
14. James S.H., Kimberlin D.W. Neonatal herpes simplex virus infection: epidemiology and treatment. Clin Perinatol. 2015; 42 (1): 47-59.
15. Kamilov H.P., Kamalova M.Q. Use of lazer therapy in the treatment of chronic reccurent herpetic stomatitis for for children. European science review. 2018; 7-8: 120-121.
16. Kuznetzova O.Y., Nesterov O.V., Maksimovskaya L.N. Complex treatment of recurrent herpetic stomatitis with dysbiosis. Stomatologia (Mosk). 2018; 97 (4): 16-18.
17.
Review
For citations:
Kamilov K.P., Lukina G.I., Shokirova F.A., Sharipova G.I. Results of integrated treatment of herpetic stomatitis with the inclusion of lipid concentrate of ERYX biomass. Endodontics Today. 2020;18(3):26-31. (In Russ.) https://doi.org/10.36377/1683-2981-2020-18-3-26-31
Email this article 